# Darling Ingredients Inc.: overview

DAR · NYSE · CIK 916540 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Jan 2

Pages: [Overview](/companies/dar.md) · [Financials](/companies/dar/financials.md) · [Filings](/companies/dar/filings.md) · [Insiders](/companies/dar/insiders.md)

Latest reported revenue: [$1.72bn](/filings/0000916540-26-000023.md) for Q2 FY2026, three months to 2026-07-04, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000916540-26-000023).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,422](/filings/0000916540-25-000031.md) | [1,418 d](/filings/0000916540-26-000008.md) | [1,381](/filings/0000916540-26-000013.md) | [1,482](/filings/0000916540-26-000023.md) | [1,564](/filings/0000916540-25-000031.md) | [1,710 d](/filings/0000916540-26-000008.md) | [1,551](/filings/0000916540-26-000013.md) | [1,724](/filings/0000916540-26-000023.md) |
| Gross margin | % | [22.1%](/filings/0000916540-25-000031.md) | [23.5% d](/filings/0000916540-26-000008.md) | [22.6%](/filings/0000916540-26-000013.md) | [23.3%](/filings/0000916540-26-000023.md) | [24.7%](/filings/0000916540-25-000031.md) | [25.1% d](/filings/0000916540-26-000008.md) | [26.1%](/filings/0000916540-26-000013.md) | [29.2%](/filings/0000916540-26-000023.md) |
| Operating margin | % | [4.2%](/filings/0000916540-25-000031.md) | [8.6% d](/filings/0000916540-26-000008.md) | [2.1%](/filings/0000916540-26-000013.md) | [5.1%](/filings/0000916540-26-000023.md) | [4.6%](/filings/0000916540-25-000031.md) | [5.7% d](/filings/0000916540-26-000008.md) | [14.6%](/filings/0000916540-26-000013.md) | [32.2%](/filings/0000916540-26-000023.md) |
| Net margin | % | [1.2%](/filings/0000916540-25-000031.md) | [7.2% d](/filings/0000916540-26-000008.md) | [(1.9%)](/filings/0000916540-26-000013.md) | [0.9%](/filings/0000916540-26-000023.md) | [1.2%](/filings/0000916540-25-000031.md) | [3.3% d](/filings/0000916540-26-000008.md) | [8.7%](/filings/0000916540-26-000013.md) | [22.5%](/filings/0000916540-26-000023.md) |
| Diluted EPS | $ per share | [0.11](/filings/0000916540-25-000031.md) | not reported | [(0.16)](/filings/0000916540-26-000013.md) | [0.08](/filings/0000916540-26-000023.md) | [0.12](/filings/0000916540-25-000031.md) | not reported | [0.83](/filings/0000916540-26-000013.md) | [2.41](/filings/0000916540-26-000023.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2022-01-01) | FY2022 (2022-12-31) | FY2023 (2023-12-30) | FY2024 (2024-12-28) | FY2025 (2026-01-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,741](/filings/0000916540-24-000009.md) | [6,532](/filings/0000916540-25-000008.md) | [6,788](/filings/0000916540-26-000008.md) | [5,715](/filings/0000916540-26-000008.md) | [6,136](/filings/0000916540-26-000008.md) |
| Gross margin | % | not reported | [23.4%](/filings/0000916540-25-000008.md) | [24.2%](/filings/0000916540-26-000008.md) | [22.4%](/filings/0000916540-26-000008.md) | [24.0%](/filings/0000916540-26-000008.md) |
| Operating margin | % | [18.7%](/filings/0000916540-24-000009.md) | [15.8%](/filings/0000916540-25-000008.md) | [14.0%](/filings/0000916540-26-000008.md) | [8.2%](/filings/0000916540-26-000008.md) | [4.5%](/filings/0000916540-26-000008.md) |
| Net margin | % | [13.7%](/filings/0000916540-24-000009.md) | [11.3%](/filings/0000916540-25-000008.md) | [9.5%](/filings/0000916540-26-000008.md) | [4.9%](/filings/0000916540-26-000008.md) | [1.0%](/filings/0000916540-26-000008.md) |
| Diluted EPS | $ per share | [3.90](/filings/0000916540-24-000009.md) | [4.49](/filings/0000916540-25-000008.md) | [3.99](/filings/0000916540-26-000008.md) | [1.73](/filings/0000916540-26-000008.md) | [0.39](/filings/0000916540-26-000008.md) |
| Free cash flow | $m | [430](/filings/0000916540-24-000009.md) | [422](/filings/0000916540-25-000008.md) | [344](/filings/0000916540-26-000008.md) | [507](/filings/0000916540-26-000008.md) | [679](/filings/0000916540-26-000008.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Gross profit: us-gaap:GrossProfit.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/dar/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $851.5m | 15,588,612 |  | Added +439,805 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $456.2m | 8,352,255 |  | Added +1,011,907 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $448.8m | 8,217,885 |  | Added +150,914 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $392.8m | 7,191,158 |  | Added +69,319 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $311.4m | 5,703,033 |  | Added +245,968 |
| [EARNEST PARTNERS LLC](/funds/1102578.md) | 2026-06-30 | $222.6m | 4,076,107 |  | Reduced −119,972 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $220.5m | 4,036,317 |  | Added +1,082,342 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $211.7m | 3,961,552 |  | Added +248,255 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $205.2m | 3,757,112 |  | Reduced −629,446 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $189.2m | 3,462,814 |  | Added +529,606 |

## Recent filings

[All 1,354 filings](/companies/dar/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 10:51 ET | [8-K](/filings/0000916540-26-000025.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000916540-26-000025 |
| 2026-08-07 | 20:21 ET | [10-Q](/filings/0000916540-26-000023.md) | Quarterly report, period 2026-07-04 | 0000916540-26-000023 |
| 2026-08-05 | 20:52 ET | [8-K](/filings/0000916540-26-000021.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000916540-26-000021 |
| 2026-07-30 | 10:40 ET | [8-K](/filings/0000916540-26-000019.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000916540-26-000019 |
| 2026-05-11 | 12:01 ET | [8-K](/filings/0000916540-26-000017.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000916540-26-000017 |
| 2026-05-08 | 20:22 ET | [8-K](/filings/0000916540-26-000015.md) | 5.07 Shareholder vote results | 0000916540-26-000015 |
| 2026-05-08 | 20:18 ET | [10-Q](/filings/0000916540-26-000013.md) | Quarterly report, period 2026-04-04 | 0000916540-26-000013 |
| 2026-04-30 | 10:41 ET | [8-K](/filings/0000916540-26-000011.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000916540-26-000011 |
| 2026-03-19 | 20:27 ET | [DEF 14A](/filings/0001193125-26-116042.md) | Proxy statement, period 2026-05-07 | 0001193125-26-116042 |
| 2026-03-03 | 21:18 ET | [10-K](/filings/0000916540-26-000008.md) | Annual report, period 2026-01-03 | 0000916540-26-000008 |

## Latest annual report

[Form 10-K for the fiscal year ended Jan 3, 2026](/filings/0000916540-26-000008.md), filed Mar 3, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 916540
- Tickers: DAR
- Exchange: NYSE
- SIC code: 2070 Fats & Oils
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.